Updated efficacy results from XELOX-1/NO16966, a randomized phase III trial in first-line metastatic colorectal cancer: Analysis of bevacizumab in combination with xelox or FOLFOX4 Meeting Abstract
| Authors: | Saltz, L.; Clarke, S.; Díaz-Rubio, E.; Scheithauer, W.; Figer, A.; Wong, R.; Koski, S.; Lichinitser, M.; Yang, R.; Cassidy, J. |
| Abstract Title: | Updated efficacy results from XELOX-1/NO16966, a randomized phase III trial in first-line metastatic colorectal cancer: Analysis of bevacizumab in combination with xelox or FOLFOX4 |
| Meeting Title: | 9th World Congress on Gastrointestinal Cancer |
| Journal Title: | Annals of Oncology |
| Volume: | 18 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2007 Jun 28-Jul 1 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2007-06-01 |
| Start Page: | vii21 |
| Language: | English |
| ACCESSION: | WOS:000249280800034 |
| PROVIDER: | wos |
| PUBMED: | 17926362 |
| DOI: | 10.1093/annonc/mdm211 |
| Notes: | Meeting Abstract: O-0032 - Oral Presentation - 9th World Congress on Gastrointestinal Cancer - JUN 28-JUL 01, 2007 - Barcelona, SPAIN - "Source: Wos" |
